USE OF FOLLISTATIN TO MODULATE GDF-8 AND BMP-11

PROBLEM TO BE SOLVED: To provide a composition for treating muscle-associated diseases containing follistatin or its functional fragment. SOLUTION: A method is to block the influence over cell of protein chosen from a group consisting of a growth and differentiation factor 8 (GDF-8), and bone morpho...

Full description

Saved in:
Bibliographic Details
Main Authors WOOD CLIVE R, FITZ LORI JO
Format Patent
LanguageEnglish
Published 09.09.2010
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a composition for treating muscle-associated diseases containing follistatin or its functional fragment. SOLUTION: A method is to block the influence over cell of protein chosen from a group consisting of a growth and differentiation factor 8 (GDF-8), and bone morphogenetic protein 11 (BMP-11), and includes medicating cell with the follistatin of an effective amount for diseases relevant to the influence of GDF-8 or BMP-11 over nerve or muscle. COPYRIGHT: (C)2010,JPO&INPIT
Bibliography:Application Number: JP20100061242